Document Detail


An acute rise in intraluminal pressure shifts the mediator of flow-mediated dilation from nitric oxide to hydrogen peroxide in human arterioles.
MedLine Citation:
PMID:  25260615     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Endothelial nitric oxide (NO) is the primary mediator of flow-mediated dilation (FMD) in human adipose microvessels. Impaired NO-mediated vasodilation occurs after acute and chronic hypertension, possibly due to excess generation of reactive oxygen species (ROS). The direct role of pressure elevation in this impairment of human arteriolar dilation is not known. We tested the hypothesis that elevation in pressure is sufficient to impair FMD. Arterioles were isolated from human adipose tissue and cannulated, and vasodilation to graded flow gradients was measured before and after exposure to increased intraluminal pressure (IILP; 150 mmHg, 30 min). The mediator of FMD was determined using pharmacological agents to reduce NO [N(G)-nitro-l-arginine methyl ester (l-NAME), 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (c-PTIO)], or H2O2 [polyethylene glycol (PEG)-catalase], and mitochondrial (mt) ROS was quantified using fluorescence microscopy. Exposure to IILP decreased overall FMD (max %dilation: 82.7 ± 4.9 vs. 62 ± 5.6; P < 0.05). This dilation was abolished by treatment with l-NAME prepressure and PEG-catalase after IILP (max %dilation: l-NAME: 23.8 ± 6.1 vs. 74.8 ± 8.6; PEG-catalase: 71.8 ± 5.9 vs. 24.6 ± 10.6). To examine if this change was mediated by mtROS, FMD responses were measured in the presence of the complex I inhibitor rotenone or the mitochondrial antioxidant mitoTempol. Before IILP, FMD was unaffected by either compound; however, both inhibited dilation after IILP. The fluorescence intensity of mitochondria peroxy yellow 1 (MitoPY1), a mitochondria-specific fluorescent probe for H2O2, increased during flow after IILP (%change from static: 12.3 ± 14.5 vs. 127.9 ± 57.7). These results demonstrate a novel compensatory dilator mechanism in humans that is triggered by IILP, inducing a change in the mediator of FMD from NO to mitochondria-derived H2O2.
Authors:
Andreas M Beyer; Matthew J Durand; Joseph Hockenberry; T Clark Gamblin; Shane A Phillips; David D Gutterman
Related Documents :
16201455 - Antihypertensive effect of total flavonoid fraction of astragalus complanatus in hypert...
3958485 - Cardiac dimensions in spontaneously hypertensive rats following different modes of bloo...
1526065 - Characterization of the baroreceptor heart rate reflex during development in spontaneou...
2095385 - Parathyroid hypertensive factor.
21605275 - Exhaled air dispersion and removal is influenced by isolation room size and ventilation...
12719445 - Heritability of blood pressure and hemodynamics in african- and european-american youth.
Publication Detail:
Type:  Journal Article     Date:  2014-09-26
Journal Detail:
Title:  American journal of physiology. Heart and circulatory physiology     Volume:  307     ISSN:  1522-1539     ISO Abbreviation:  Am. J. Physiol. Heart Circ. Physiol.     Publication Date:  2014 Dec 
Date Detail:
Created Date:  2014-12-02     Completed Date:  -     Revised Date:  2014-12-09    
Medline Journal Info:
Nlm Unique ID:  100901228     Medline TA:  Am J Physiol Heart Circ Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  H1587-93     Citation Subset:  IM    
Copyright Information:
Copyright © 2014 the American Physiological Society.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Detecting calcium in cardiac muscle: Fluorescence to dye for.
Next Document:  Regulation of Notch 1 signaling in THP-1 cells enhances M2 macrophage differentiation.